ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 635157 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 635157; 2) Community: the network communities that were significantly associated with the response to NSC 635157; 3) Molecule: the relationships between components within communities and NSC 635157; 4) MDR: the compounds that were significantly associated with the NSC 635157.

NSC Compound Enrichment Correlation
NSC 746687 (2E)-3-(2-phenyl-1H-indol-3-yl)-2-(phenylsulfonyl)acrylonitrile 0.0376362543535815 0.43793248
NSC 755423 Null 0.0376362543535815 0.19151584
NSC 756170 GSK317315A 0.0376362543535815 0.25940118
NSC 758356 2-(1-(4-chlorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide 0.0376362543535815 0.3084346
NSC 83343 Null 0.0376362543535815 -0.13982035
NSC 83492 Null 0.0376362543535815 0.36986987
NSC 697167 Null 0.038267585766958 0.081729077
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.038267585766958 0.14509231
NSC 638646 4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride 0.0382675857669585 0.42778606
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.0382675857669585 0.36802813
Total:77  Current:60    [First] [Prev] [Next] [Last]